Genomics and Insurance in the United Kingdom: Increasing Complexity and Emerging Challenges (Updated April 21, 2023): Social Sciences
2023 MAY 08 (NewsRx) -- By a
“This article identifies issues relating to the use of genetics and genomics in insurance that may challenge existing regulatory models in the
“We discuss three core issues: (1) As genomic testing advances, and results are increasingly relevant to guide healthcare across an individual’s lifetime, the distinction between diagnostic and predictive testing that the current
“We also outline the broad scope of possible regulatory responses to these developments. At present in the
“We suggest a deliberative approach is required to establish where these deviations from actuarially fair pricing should be upheld, and whether there might be situations in which they should be withdrawn.”
This preprint has not been peer-reviewed.
For more information on this research see: http://osf.io/preprints/socarxiv/p3hsy/
(Our reports deliver fact-based news of research and discoveries from around the world.)
“Methods And Systems For Anonymizing Genome Segments And Sequences And Associated Information” in Patent Application Approval Process (USPTO 20230124077): Patent Application
More insurance changes are in store from the Legislature. Here’s what they mean to you [South Florida Sun-Sentinel]
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News